VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
View all videos

ESMO 2022

European Society for Medical Oncology Congress 2022
01 September 2022 | Paris, France
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

ESMO 2022

European Society for Medical Oncology Congress 2022
01 September 2022 | Paris, France
VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
View all videos
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

Latest videos from ESMO 2022!

View all
1:19
CAR-T in solid tumors: challenges and future directions
Jon Amund Kyte • 9 Sep 2022
1:15
Recent advances in the management of STS
Patrick Schöffski • 9 Sep 2022
0:30
What to look forward to in GU at ESMO 2022?
Michiel Strijbos • 9 Sep 2022
1:20
Upcoming GU cancer trials to be presented at ESMO 2022
Nicholas James • 9 Sep 2022

GU at ESMO 2022!

View all
0:30
What to look forward to in GU at ESMO 2022?
Michiel Strijbos • 9 Sep 2022
1:20
Upcoming GU cancer trials to be presented at ESMO 2022
Nicholas James • 9 Sep 2022
1:11
Unmet needs in treating oligometastatic prostate cancer
Nicholas James • 9 Sep 2022
1:38
STEAP1 targeting CAR for adoptive cell therapy against cancer
Jon Amund Kyte • 9 Sep 2022

GI at ESMO 2022!

View all
1:22
Influence of sidedness on prognosis and treatment in mCRC
Chiara Cremolini • 9 Sep 2022
2:22
Interpreting real-world data to better manage patients with mCRC
Chiara Cremolini • 9 Sep 2022
2:02
Phase I dose-escalation and expansion study evaluating BI 907828 in patients with solid tumours
Patrick Schöffski • 9 Sep 2022
2:28
The evolving treatment paradigm for BRAF V600E-mutant mCRC
Sebastian Stintzing • 10 Sep 2022

Breast cancer at ESMO 2022!

View all
3:15
ICON: chemotherapy combined with ipilimumab and nivolumab in metastatic HR+ breast cancer
Jon Amund Kyte • 9 Sep 2022
3:52
Sexual health after breast cancer: longitudinal assessment of PROs
Maria Alice Franzoi • 9 Sep 2022
2:30
Patient-reported outcomes from DESTINY-Breast04
Naoto Ueno • 10 Sep 2022
4:17
Impact of age, RS and OFS on endocrine response to short preoperative ET
Oleg Gluz • 10 Sep 2022

Previous ESMO Coverage

ESMO 2021
ESMO 2020
ESMO 2019
ESMO 2018
ESMO 2017
ESMO 2016

Stay tuned for interviews with the following doctors and more...

Erika Hamilton
MD
Sarah Cannon Cancer Center, Nashville, TN
Martin Reck
MD, PhD
Hospital Grosshansdorf, Germany
Enrique Grande
MD, PhD
MD Anderson Cancer Center Madrid, Madrid, Spain
Sanjay Popat
MBBS, FRCP, PhD
The Royal Marsden NHS Foundation Trust, London, UK
Paolo Ascierto
MD
National Tumor Institute Fondazione G. Pascale, Naples, Italy
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals